171 related articles for article (PubMed ID: 20809466)
21. Long-term immunogenicity and efficacy of a recombinant hepatitis B vaccine in Egyptian children.
el-Sawy IH; Mohamed ON
East Mediterr Health J; 1999 Sep; 5(5):922-32. PubMed ID: 10983531
[TBL] [Abstract][Full Text] [Related]
22. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005).
Alavian SM; Mansouri S; Abouzari M; Assari S; Bonab MS; Miri SM
Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):131-4. PubMed ID: 18188034
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
Halota W; Muszyńska M; Pawłowska M
Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201
[TBL] [Abstract][Full Text] [Related]
24. Long-term protection of hepatitis B vaccine 18 years after vaccination.
Alfaleh F; Alshehri S; Alansari S; Aljeffri M; Almazrou Y; Shaffi A; Abdo AA
J Infect; 2008 Nov; 57(5):404-9. PubMed ID: 18829116
[TBL] [Abstract][Full Text] [Related]
25. A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination.
Zhang L; Xu A; Yan B; Song L; Li M; Xiao Z; Xu Q; Li L
Int J Infect Dis; 2010 Jun; 14(6):e483-8. PubMed ID: 19939719
[TBL] [Abstract][Full Text] [Related]
26. Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program.
Su FH; Chen JD; Cheng SH; Lin CH; Liu YH; Chu FY
J Med Virol; 2007 Feb; 79(2):138-43. PubMed ID: 17177303
[TBL] [Abstract][Full Text] [Related]
27. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
de la Hoz F; Perez L; de Neira M; Hall AJ
Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
29. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine].
Zhuang GH; Yan H; Wang XL; Wu Q; Wang LR; Gao HY
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):8-12. PubMed ID: 16620590
[TBL] [Abstract][Full Text] [Related]
30. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
[TBL] [Abstract][Full Text] [Related]
31. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
[TBL] [Abstract][Full Text] [Related]
32. [Study on the immuno-effects of recombinant hepatitis B vaccination in adults].
Zhang FM; Zhao QX; Han JH; Zhou QH; Wang MC; Miao W; Li R
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Aug; 24(8):697-9. PubMed ID: 14521791
[TBL] [Abstract][Full Text] [Related]
33. [Respective importance of vertical and horizontal transmission of hepatitis B in the Australian archipelago (French Polynesia). Preliminary results of the vaccination of newborns].
Boutin JP; Spiegel A; Flye Sainte-Marie F; Cartel JL; Girard M; Saliou P; Roux J
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):906-11. PubMed ID: 1840244
[TBL] [Abstract][Full Text] [Related]
34. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
35. [A study on the relationship between maximal titers of anti-HBs antibodies and persistence of protective level after vaccination].
Li SQ
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Jun; 13(3):134-7. PubMed ID: 1423534
[TBL] [Abstract][Full Text] [Related]
36. The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine.
Ural O; Findik D
J Infect; 2001 Oct; 43(3):187-90. PubMed ID: 11798257
[TBL] [Abstract][Full Text] [Related]
37. [Significance of the "isolated anti-HBc" serological pattern determinated by the serological response to the vaccination against Hepatitis B].
Coz Yataco A; Lozano Miranda A; Samalvides Cuba F; Antunez de Mayolo Ramis E
Rev Gastroenterol Peru; 2005; 25(3):254-8. PubMed ID: 16237469
[TBL] [Abstract][Full Text] [Related]
38. [Long-term efficacy of vaccination against hepatitis B in newborns: 13 years' follow-up].
Wu W; Sun C; Jiang M; Xu Y; Zhang GH; Liu CB; Cao HL; Lin XM; Xu ZY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):239-41. PubMed ID: 11986695
[TBL] [Abstract][Full Text] [Related]
39. Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania.
Pippi F; Bracciale L; Stolzuoli L; Giaccherini R; Montomoli E; Gentile C; Filetti S; De Luca A; Cellesi C
HIV Med; 2008 Aug; 9(7):519-25. PubMed ID: 18554311
[TBL] [Abstract][Full Text] [Related]
40. [A study on the effectiveness of hepatitis B vaccine among the vaccinated population].
Wang C; Li D
Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Feb; 19(1):43-6. PubMed ID: 10322708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
